Published in Arch Dis Child on June 01, 1993
Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis. Eur Arch Otorhinolaryngol (1995) 0.99
Interleukin-1. Rev Infect Dis (1984) 11.24
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest (1989) 10.59
Stimulation of neutrophils by tumor necrosis factor. J Immunol (1986) 5.72
An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. J Immunol (1986) 5.14
Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol (1987) 4.75
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (1980) 4.29
Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A (1976) 3.62
Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet (1985) 3.32
Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol (1979) 3.32
Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis (1973) 2.28
The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol (1976) 2.09
Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis (1985) 2.04
Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Respir Dis (1989) 1.99
Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta. Am J Respir Cell Mol Biol (1990) 1.98
Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. Arch Dis Child (1993) 1.94
Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis (1990) 1.54
Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study. J Pediatr (1984) 1.48
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A (1990) 1.38
Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease. Arch Dis Child (1992) 1.33
Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci U S A (1986) 1.28
Relationships among digital clubbing, disease severity, and serum prostaglandins F2alpha and E concentrations in cystic fibrosis patients. Am Rev Respir Dis (1978) 1.22
Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. Am Rev Respir Dis (1991) 1.21
Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis (1990) 1.21
Recombinant human tumour necrosis factor (rTNF)2 enhances leukotriene biosynthesis in neutrophils and eosinophils stimulated with the Ca2+ ionophore A23187. Clin Exp Immunol (1987) 1.21
Interactions of Pseudomonas aeruginosa proteases with the cells of the immune system. Antibiot Chemother (1971) (1989) 1.19
Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res (1986) 1.17
Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. J Immunol (1991) 1.11
Leukotrienes in the sputum and urine of cystic fibrosis children. Br J Clin Pharmacol (1990) 1.10
Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors. Clin Exp Immunol (1987) 1.05
Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection. Acta Pathol Microbiol Scand C (1978) 1.00
Serum leukotriene B4 levels in patients with obstructive pulmonary disease. Chest (1991) 0.99
Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency. Pediatr Res (1986) 0.98
Risks of alternate-day prednisone in patients with cystic fibrosis. Pediatrics (1991) 0.96
Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Acta Paediatr Scand (1983) 0.93
Immune complexes and complement abnormalities in patients with cystic fibrosis. Increased mortality associated with circulating immune complexes and decreased function of the alternative complement pathway. Am Rev Respir Dis (1985) 0.93
Platelet hyperaggregability in cystic fibrosis. Prostaglandins Leukot Med (1987) 0.89
Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis. Thorax (1986) 0.83
Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis. Immunology (1991) 0.77
Use of post-exercise laryngoscopy to evaluate exercise induced dyspnea. Pediatr Pulmonol (2010) 1.39
Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis. Pediatr Pulmonol (2001) 1.09
Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8. Am J Physiol Lung Cell Mol Physiol (2000) 1.03
Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. J Cyst Fibros (2011) 0.96
High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations. Thorax (2010) 0.88
A decade of non-cystic fibrosis bronchiectasis 1996-2006. Ir Med J (2010) 0.81
Peripheral muscle strength in young males with cystic fibrosis. J Cyst Fibros (2002) 0.81
Altered intracellular pH regulation in neutrophils from patients with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol (2000) 0.80
Asthma control and management: a patient's perspective. Ir Med J (2006) 0.78
Human recombinant DNase for mucus plugging in status asthmaticus. Lancet (1995) 0.78
Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis. Ir Med J (2009) 0.77
Pleuropulmonary blastoma type I following resection of incidentally found congenital lobar emphysema. Ir Med J (2009) 0.76
Interleukin-1 alpha and soluble interleukin-2 receptor in atopic dermatitis. Arch Dis Child (1992) 0.75
The changing epidemiology of the bronchiolitis epidemic in Tallaght Hospital. Ir Med J (2014) 0.75
Diagnosis and treatment of sleep related breathing disorders in children: 2007 to 2011. Ir Med J (2015) 0.75
Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Ir Med J (2009) 0.75
Airway function tests and vocal cord paralysis in lung transplant recipients. Pediatr Pulmonol (1997) 0.75
Physical activity and cardiovascular disease risk factors in urban school children. Ir Med J (2013) 0.75